Brind.

Artelo Biosciences published research findings in an academic journal, announcing results from company headquarters and conference presentations in locations including Solana Beach and Dijon.

1 report, 1 independent Updated Jun 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Artelo Biosciences published research findings in an academic journal, announcing results from company headquarters and conference presentations in locations including Solana Beach and Dijon.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Artelo Biosciences is evaluating its novel synthetic cannabinoid, ART27.13, for the treatment of glaucoma.Sub-event
  2. Artelo Biosciences published research findings involving Cornell University and Solana Beach.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped